Friday, March 29, 2024

Bharat Biotech complete enrollment of 25,800 volunteers for Covaxin Phase-3 trials

Must Read

By PTI
HYDERABAD: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin, Suchitra Ella, joint managing director, Bharat Biotech International Ltd said on Thursday.

In a message posted on the company’s Twitter account, she thanked clinical trial sites, principal investigators and health workers for their support and trust in the “public- private partnership” vaccine discovery.

ALSO READ: Tamil Nadu to hold second COVID-19 vaccination dry run on Friday, this time in all districts

“My deep appreciation to all the volunteers for reposing and expressing Pro Vaccine Public Health Voluntarism in the phase-3 clinical trials of India’s 1st fully indigenous COVID-19 vaccine,” she said referring to Covaxin.

The Drug Controller General of India (DCGI) has recently given Emergency Use Authorisation for Covaxin.

ALSO READ: India, Sri Lanka looking at post-COVID cooperation: External Affairs Minister S Jaishankar

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.

The company had said it is the only Phase-3 efficacy study for a COVID-19 vaccine, and the largest efficacy trial (Phase-3) ever conducted for any vaccine in India.

Latest News

The wait of the fans is over, the release date of Heeramandi has been announced…

People are eagerly waiting for director Sanjay Leela Bhansali's film 'Heeramandi: The Diamond Bazaar'. #HeeramandiKabReleaseHogi is also trending...